Li X - Search Results

1

Chidamide plus R-GDP for relapsed/refractory diffuse large B-cell lymphoma in patients ineligible for autologous transplantation: A prospective, single-arm, phase II study.

Chen GL, Xue K, Zhang Q, Xia ZG, Jin J, Li R, Liu Y, Lv F, Hong X, Li X, Cao J. Chen GL, et al. Among authors: li x, li r. Cancer Med. 2024 Aug;13(16):e70142. doi: 10.1002/cam4.70142. Cancer Med. 2024. PMID: 39206577 Free PMC article. Clinical Trial.

2

[Prognostic predictors of nasal NK/T cell lymphoma detected by immunohistochemical staining].

Wang BY, Hong XN, Yin JL, Lu HF, Li XQ, Ma XJ, Guo Y. Wang BY, et al. Zhonghua Zhong Liu Za Zhi. 2006 Jul;28(7):523-5. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17147118 Chinese.

3

Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.

Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J. Guo Y, et al. Among authors: li j, li x. Oral Oncol. 2008 Jan;44(1):23-30. doi: 10.1016/j.oraloncology.2006.11.020. Epub 2007 Feb 15. Oral Oncol. 2008. PMID: 17306611

4

Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type.

Wang B, Li XQ, Ma X, Hong X, Lu H, Guo Y. Wang B, et al. Among authors: li xq. Am J Hematol. 2008 Oct;83(10):795-9. doi: 10.1002/ajh.21256. Am J Hematol. 2008. PMID: 18756548 Free article.

5

Oral fludarabine in combination with doxorubicin and dexamethasone as first-line therapy for nodal peripheral T-cell lymphomas: early results of a prospective multicenter study.

Liu XJ, Guo Y, Fan Y, Gu KS, Cao JN, Wu XH, Zhang J, Li XQ, Wang CF, Hong XN. Liu XJ, et al. Cancer Chemother Pharmacol. 2012 Feb;69(2):387-95. doi: 10.1007/s00280-011-1711-z. Epub 2011 Jul 26. Cancer Chemother Pharmacol. 2012. PMID: 21789688 Clinical Trial.

6

[Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns].

Wang L, Wang W, Li X, Guo Y, Zhu X. Wang L, et al. Among authors: li x. Zhonghua Bing Li Xue Za Zhi. 2014 May;43(5):307-12. Zhonghua Bing Li Xue Za Zhi. 2014. PMID: 25030862 Chinese.

7

Cardiotoxicity as indicated by LVEF and troponin T sensitivity following two anthracycline-based regimens in lymphoma: Results from a randomized prospective clinical trial.

Xue K, Gu JJ, Zhang Q, Liu X, Wang J, Li XQ, Luo J, Hernandez-Ilizaliturri FJ, Fernandez SF, Czuczman MS, Cao J, Hong X, Guo Y. Xue K, et al. Among authors: li xq. Oncotarget. 2016 May 31;7(22):32519-31. doi: 10.18632/oncotarget.8685. Oncotarget. 2016. PMID: 27081036 Free PMC article. Clinical Trial.

8

MYC protein dysregulation is driven by BCR-PI3K signalling in diffuse large B-cell lymphoma.

Wang WG, Liu ZB, Jiang XN, Lee J, Zhou XY, Li XQ. Wang WG, et al. Histopathology. 2017 Nov;71(5):778-785. doi: 10.1111/his.13287. Epub 2017 Sep 15. Histopathology. 2017. PMID: 28639315

9

Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature.

Jiang XN, Yu BH, Wang WG, Zhou XY, Li XQ. Jiang XN, et al. PLoS One. 2017 Jun 30;12(6):e0178416. doi: 10.1371/journal.pone.0178416. eCollection 2017. PLoS One. 2017. PMID: 28665943 Free PMC article. Review.

10

Epstein-Barr virus-positive diffuse large B-cell lymphoma features disrupted antigen capture/presentation and hijacked T-cell suppression.

Jiang XN, Yu BH, Yan WH, Lee J, Zhou XY, Li XQ. Jiang XN, et al. Oncoimmunology. 2019 Nov 3;9(1):1683346. doi: 10.1080/2162402X.2019.1683346. eCollection 2020. Oncoimmunology. 2019. PMID: 32002294 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178,417 results

Search Page

Filters